Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients. [electronic resource]
- Scientific reports 02 2020
- 1840 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-020-58760-7 doi
Aged Biomarkers--blood Cardiovascular Diseases--blood Diabetes Mellitus, Type 2--blood Female Humans Linear Models Male Metabolic Syndrome--blood Middle Aged Osteocalcin--blood Risk Assessment Risk Factors